We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+9.92%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$233M
AUM Growth
+$68M
Cap. Flow
+$60.5M
Cap. Flow %
25.93%
Top 10 Hldgs %
45.5%
Holding
74
New
30
Increased
14
Reduced
14
Closed
14

Top Buys

Rank Stock Value
1
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
+$6.96M
2
AMZN icon
Amazon
AMZN
+$6.09M
3
ISRG icon
Intuitive Surgical
ISRG
+$5.32M
4
ULTA icon
Ulta Beauty
ULTA
+$5.01M
5
AGN
Allergan plc
AGN
+$4.61M

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$6.8M
2
SFM icon
Sprouts Farmers Market
SFM
+$6.45M
3
MSFT icon
Microsoft
MSFT
+$6.26M
4
META icon
Meta Platforms (Facebook)
META
+$4.84M
5
NFLX icon
Netflix
NFLX
+$4.52M

Sector Composition

Rank Sector Weight
1 Healthcare 23.76%
2 Consumer Discretionary 18.13%
3 Communication Services 11.81%
4 Materials 7.01%
5 Industrials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LKFT
51
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
$1.17M 0.5%
+21,000
New +$1.06M
ADSK icon
52
Autodesk
ADSK
$49.6B
$1.16M 0.5%
21,500
-68,500
-76% -$3.96M
STRP
53
DELISTED
Straight Path Communications Inc.
STRP
$997K 0.43%
+36,000
New +$1.19M
WBA
54
CALL
DELISTED
Walgreens Boots Alliance
WBA
$991K 0.42%
11,900
-23,800
-67% -$1.92M
SKX
55
DELISTED
Skechers
SKX
$951K 0.41%
32,000
-55,000
-63% -$1.66M
TSRO
56
DELISTED
TESARO, Inc.
TSRO
$883K 0.38%
+10,500
New +$468K
XLRN
57
DELISTED
Acceleron Pharma
XLRN
$816K 0.35%
+24,000
New +$780K
ALNY icon
58
Alnylam Pharmaceuticals
ALNY
$27.5B
$777K 0.33%
+14,000
New +$882K
ALXN
59
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
$467K 0.2%
+4,000
New +$568K
ACAD icon
60
CALL
Acadia Pharmaceuticals
ACAD
$4.55B
$334K 0.14%
10,300
– –
AAP icon
61
Advance Auto Parts
AAP
$3.39B
– –
-16,000
Closed -$2.56M
BIDU icon
62
Baidu
BIDU
$36.5B
– –
-8,000
Closed -$1.53M
BMRN icon
63
BioMarin Pharmaceuticals
BMRN
$11.7B
– –
-24,000
Closed -$1.98M
EEM icon
64
iShares MSCI Emerging Markets ETF
EEM
$28.6B
– –
-80,000
Closed -$2.74M
EW icon
65
Edwards Lifesciences
EW
$50B
– –
-42,000
Closed -$1.23M
GDX icon
66
VanEck Gold Miners ETF
GDX
$23.5B
– –
-116,500
Closed -$2.33M
HD icon
67
Home Depot
HD
$332B
– –
-51,000
Closed -$6.8M
NVCR icon
68
CALL
NovoCure
NVCR
$1.77B
– –
-25,200
Closed -$365K
SFM icon
69
Sprouts Farmers Market
SFM
$8.1B
– –
-222,000
Closed -$6.45M
TPR icon
70
Tapestry
TPR
$30.8B
– –
-55,000
Closed -$2.21M
WBA
71
DELISTED
Walgreens Boots Alliance
WBA
– –
-49,000
Closed -$3.95M
DNKN
72
DELISTED
Dunkin' Brands Group, Inc.
DNKN
– –
-30,000
Closed -$1.42M
PTLA
73
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-27,500
Closed -$561K
MDVN
74
DELISTED
MEDIVATION, INC.
MDVN
– –
-78,900
Closed -$3.63M
1 2
3

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Atika Capital Management held 74 positions worth $233M, up 41% from $165M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Atika Capital Management deployed $60.5M of net new capital in Q2 2016, opening 30 new positions and adding to 14 existing holdings. Its largest new stake was RAPTOR PHARMACEUTICAL CORP COM STK (DE): 1,358,000 shares worth $7.29M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Microsoft, an estimated $6.26M trimmed.

  • Atika Capital Management's largest Q2 2016 buy was RAPTOR PHARMACEUTICAL CORP COM STK (DE): 1,358,000 shares worth $7.29M.
  • Atika Capital Management added most to Allergan plc in Q2 2016, an estimated $4.61M increase.
  • Atika Capital Management's biggest Q2 2016 reduction was Microsoft, cutting an estimated $6.26M.
  • Atika Capital Management fully exited Home Depot in Q2 2016, selling an estimated $6.8M.
  • Atika Capital Management's ten largest holdings make up 45% of its $233M portfolio in Q2 2016.
  • Atika Capital Management opened 30 new positions and closed 14 in Q2 2016.
  • Atika Capital Management's portfolio value rose 41% quarter-over-quarter to $233M.

Based on Atika Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.